TrialThe Journal of allergy and clinical immunology2017
A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma.
Maryann Kaler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it